Clinical Trials
4 trialsNCT05211232 2026-05-29
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Active not recruiting
NCT07388758 2026-02-05
Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07331428 2026-01-09
MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT04215978 2025-10-03
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
BeiGene
Phase 1 Completed